Company Financials

HilleVax, Inc. Financials

United States dollar

business HilleVax, Inc. Company Profile

Main Stock Listing

NASDAQ: HLVX

Market Capitalization None as of None

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE
Forward PE -3.87
Price to Sales TTM $
Price to Book MRQ $2.41
Enterprise to Revenue
Enterprise to EBITDA -3.04

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter 2023-12-31
Profit Margin 0.00%
Operating Margin 0.00%
Return on Assets TTM -25.19%
Return on Equity TTM -46.39%

Income Statement

Revenue TTM $0
Revenue per Share TTM $
Quarterly Revenue Growth %
Gross Profit TTM $0
EBITDA $-132,466,000
Net Income to Common TTM $-123,566,000
Diluted EPS TTM $-3.04
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $303,483,008
Total Cash per Share MRQ $6.31
Total Debt MRQ $
Total Debt to Equity MRQ 19.28
Current Ratio MRQ 10.62
Book Value per Share MRQ $5.66

Cash Flow

Operating Cash Flow TTM $-86,783,000
Levered Free Cash Flow TTM $-62,114,624

HLVX Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 49,720,900
Float Shares 23,450,429
Avg 10 Volume 132,244
Avg 30 Volume None
Shares Short 498,544
Short Ratio 4.25
Short % of Shares 6.46%
% Held by Insiders 5.72%
% Held by Institutions 96.14%

Stock Price Summary

Beta
Fifty Two Week Low $9.94
Fifty Two Week High $20.22
Fifty Two Week Change -4.34%
Day 50 MA $15.63
Day 200 MA $14.28

Dividends and Splits

Forward Annual Dividend Rate $8.64
Forward Annual Dividend Yield 63.48%
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date